Not Tagged
astrazeneca
['astrazeneca']
#esmo22: astrazeneca takes different approach to ctla-4 with bispecific but toxicities remain high #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #productmarketing #pharmaceutical 
Strategy & Competitive Marketing | Digital & Social Pharma | Life Sciences Investment | Cell & Gene Therapy | Vaccines